PER-017-03已完成未知
HIV TREATMENT PROTOCOL WITH PEG-INTRON: STUDY SUB-STUDY P00737 AND STUDY P00738
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects must receive a HAART regimen at present.
- •The following laboratory parameters must be met:
- •Platelet count> 75,000/mm3
- •Hemoglobin> 9 gm / dl
- •Absolute neutrophil count> 1,000/mm3
- •Creatinine <1.5 times the upper limit of normal
- •SGOT / SGPT <5 times the normal upper limit
排除标准
- •People who are participating in clinical studies of drugs currently in research, or have done so in the previous month.
- •Subjects with a history of hypersensitivity to interferons.
- •Subjects with a history of moderate or severe depression, dementia, or other major psychiatric conditions that require medical treatment.
研究者
相似试验
已完成
2 期
Safety and Effectiveness of PEG-Intron in HIV-Infected PatientsHIV InfectionsNCT00005012Schering-Plough250
已完成
不适用
PHASE III STUDY OF PEG-INTRON IN PATIENTS INFECTED BY HIV WHO HAVE EXPERIENCED MULTIPLE TREATMENTSPER-032-02SCHERING PLOUGH RESEARCH INSTITUTE,
招募中
不适用
Clinical investigation of HIV infection diagnostic kitHIV infectionJPRN-UMIN000021201Keio University School of Medicine Center for Infectious Disease and Infection Control200
进行中（未招募）
1 期
A study of the effect of antiretroviral therapy and immunoglobulin on the HIV reservoir in Acute HIV Infection.Acute HIV InfectionMedDRA version: 14.1 Level: LLT Classification code 10000811 Term: Acute infection with HIV System Organ Class: 10021881 - Infections and infestationsEUCTR2011-001982-42-GBGuy's & St. Thomas' NHS Foundation Trust10
进行中（未招募）
不适用
Maraviroc and cardiovascular risk in HIV+ patients.HIV-1 infection.EUCTR2014-002134-31-ITOspedale L. Sacco - Azienda Ospedaliera-Polo Universitario